The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer

Ge, JS; Wang, J; Wang, H; Jiang, XJ; Liao, QJ; Gong, Q; Mo, YZ; Li, XL; Li, GY; Xiong, W; Zhao, J; Zeng, ZY

Zhao, J; Zeng, ZY (corresponding author), Cent S Univ, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.; Zhao, J; Zeng, ZY (corresponding author), Cent S Univ, Hunan Key Lab Translat Radiat Oncol, Hunan Canc Hosp, Changsha, Hunan, Peoples R China.; Zhao, J; Zeng, ZY (corresponding author), Cent S Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China.; Zhao, J; Zeng, ZY (corresponding author), Cent S Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Canc Res Inst, Changsha, Hunan, Peoples R China.; Zhao, J; Zeng, ZY (corresponding author), Cent S Univ, Sch Basic Med, Changsha, Hunan, Peoples R China.; Zeng, ZY (corresponding author), Cent S Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha, Hunan, Peoples R China.

JOURNAL OF CANCER, 2020; 11 (4): 932

Abstract

Objective: To investigate the correlation between the BRAF V600E gene mutation and clinicopathological features and thyroid function after iodine-131 ......

Full Text Link